228 related articles for article (PubMed ID: 3084360)
1. Acute leukemia occurring in a primary neoplasia (secondary leukemia). A Review of biological, epidemiological and clinical aspects.
Brusamolino E; Pagnucco G; Bernasconi C
Haematologica; 1986; 71(1):60-83. PubMed ID: 3084360
[No Abstract] [Full Text] [Related]
2. Risk of leukemia associated with the first course of cancer treatment: an analysis of the Surveillance, Epidemiology, and End Results Program experience.
Curtis RE; Hankey BF; Myers MH; Young JL
J Natl Cancer Inst; 1984 Mar; 72(3):531-44. PubMed ID: 6583439
[TBL] [Abstract][Full Text] [Related]
3. [Acute leukaemia in the course of Hodgkin's disease: report of two cases (author's transl)].
Mitrou PS; Fischer M; Martin H
Dtsch Med Wochenschr; 1974 Aug; 99(31):1596-7. PubMed ID: 4526423
[No Abstract] [Full Text] [Related]
4. [New viewpoints for indication for radiologic treatment in leukoses and retikuloses].
Musshoff K
Strahlentherapie; 1968 Jun; 135(6):641-55. PubMed ID: 4878792
[No Abstract] [Full Text] [Related]
5. Second malignancies and chemotherapeutic agents.
Kyle RA
Prog Clin Biol Res; 1983; 132E():45-54. PubMed ID: 6417671
[No Abstract] [Full Text] [Related]
6. Study of erythrocyte mean corpuscular volume during cytotoxic therapy as a predictive parameter of the risk of secondary leukemia in Hodgkin's disease.
de Gramont A; Rioux E; Drolet Y; Delage JM
Cancer Treat Rep; 1984 Dec; 68(12):1467-70. PubMed ID: 6509452
[TBL] [Abstract][Full Text] [Related]
7. Acute leukemia as a complication of cytotoxic chemotherapy.
Rosner F; Grünwald HW; Zarrabi MH
Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1705-7. PubMed ID: 536280
[No Abstract] [Full Text] [Related]
8. [Current therapy of malignant blood diseases].
de Werra P
Praxis; 1967 Jun; 56(26):901-6. PubMed ID: 5253422
[No Abstract] [Full Text] [Related]
9. Radiation and drug therapies, and leukemia.
Potolsky A; Creger WP
Annu Rev Med; 1973; 24():75-82. PubMed ID: 4514215
[No Abstract] [Full Text] [Related]
10. The effect of Milurit on secondary hyperuricaemia following cytostatic treatment in haemoblastosis patients.
Bodrogi I; Bálint I
Ther Hung; 1979; 27(2):77-83. PubMed ID: 494144
[No Abstract] [Full Text] [Related]
11. Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
Frei E; Schabel FM; Goldin A
Cancer Res; 1974 Jan; 34(1):184-93. PubMed ID: 4520419
[No Abstract] [Full Text] [Related]
12. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
13. [Corticosteroids in oncology].
Cleton FJ
Ned Tijdschr Geneeskd; 1977 Oct; 121(43):1715-20. PubMed ID: 270013
[No Abstract] [Full Text] [Related]
14. [Development of second tumors in patients with Hodgkin's disease (review of the literature and personal data)].
Kanaev SV; Kholin AV; Gershanovich ML; Malinin AP
Vopr Onkol; 1987; 33(5):11-8. PubMed ID: 3590664
[TBL] [Abstract][Full Text] [Related]
15. Second malignant neoplasms in patients successfully treated for Hodgkin's disease: a Cancer and Leukemia Group B study.
Glicksman AS; Pajak TF; Gottlieb A; Nissen N; Stutzman L; Cooper MR
Cancer Treat Rep; 1982 Apr; 66(4):1035-44. PubMed ID: 6951632
[No Abstract] [Full Text] [Related]
16. Cancer and secondary leukemia.
Rosner F
Bull Cancer; 1983; 70(1):55-60. PubMed ID: 6573207
[TBL] [Abstract][Full Text] [Related]
17. [Lithium carbonate in prevention of leukopenia/caused by antineoplastic drugs].
Orlando S; Baroni MC; Crotti G; Mineo F; Capra A; Coiro V; Delsignore R
G Clin Med; 1981 May; 62(5):351-9. PubMed ID: 6791980
[No Abstract] [Full Text] [Related]
18. [Personal experience on the chemotherapy of leukemias and hematosarcomas].
Mathé G; Schneider M; Schwarzenberg L; Cattan A; Amiel JL; Schlumberger JR
Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):245-54. PubMed ID: 4874537
[No Abstract] [Full Text] [Related]
19. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
Nand S; Stock W; Godwin J; Fisher SG
Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610
[TBL] [Abstract][Full Text] [Related]
20. Leukemia and lymphoma.
White LP
Geriatrics; 1970 Dec; 25(12):82-6. PubMed ID: 5274229
[No Abstract] [Full Text] [Related]
[Next] [New Search]
